Tocilizumab Plus Remdesivir to Be Evaluated for Severe COVID-19 Pneumonia
The trial is being conducted by Roche in collaboration with Gilead Sciences.
COVID19
Improving Glycemic Control May Also Aid COVID-19 Outcomes
Insulin infusion may reduce risk for severe disease in those with hyperglycemia and COVID-19.
MPR Weekly Dose Podcast Episode 36
This pod covers important news regarding hydroxychloroquine; The efficacy of dietary supplements as a means to manage or prevent COVID-19; The first non-hormonal contraceptive gel approved by the FDA; And an expanded approval for dupilumab.
Remdesivir Improves Time To Recovery for Patients Hospitalized With COVID-19
Treatment with remdesivir was associated with a shorter time to recovery in patients hospitalized with coronavirus disease 2019 (COVID-19), according to peer-reviewed data published in the New England Journal of Medicine.
Merck Collaborating on Novel COVID-19 Vaccine, Oral Antiviral
The vaccine candidate is currently in preclinical development with clinical studies expected to begin later this year.
WHO Suspends Testing of Hydroxychloroquine in COVID-19 Patients
In light of recent findings, hydroxychloroquine arm of WHO global study paused temporarily.
Adenovirus Type 5 Vectored COVID-19 Vaccine Tolerable, Immunogenic in Phase 1 Study
A total of 108 healthy adult volunteers 18 to 60 years old (mean age, 36.3 years old) with no history of COVID-19 infection were enrolled in the study.
Evidence Supporting Dietary Supplement Use for COVID-19 Lacking
There is a lack of evidence supporting the use of dietary supplements for the prevention or treatment of COVID-19, despite what recent news or social media platforms have asserted,
Hydroxychloroquine or Chloroquine for COVID-19: Large Study Finds No Benefit
A multinational observational study evaluating the use of hydroxychloroquine or chloroquine, either as monotherapy or with a macrolide, found that these treatments may increase the risk of ventricular arrhythmia and death in patients hospitalized with coronavirus disease 2019 (COVID-19). The analysis included 96,032 patients with laboratory confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) who…
Interim Data on Abbott ID NOW COVID-19 Rapid Test Performance Announced
An ongoing clinical study of the Abbott ID NOW™ COVID-19 rapid test shows strong agreement to lab-based molecular polymerase chain reaction (PCR) instruments.
